Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-08-16
2011-08-16
Bunner, Bridget E (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C530S350000, C530S387900, C536S023500
Reexamination Certificate
active
07998682
ABSTRACT:
A non-invasive method for the diagnosis of atherosclerosis is provided. In one example, the method includes assaying the expression of FOS, DUSP1, or both FOS and DUSP1 in monocytes or a cell fraction thereof, or in plasma, serum or peripheral blood from the subject. An increase the expression of FOS, DUSP1, or both FOS and DUSP1 in monocytes in the sample as compared to a control indicates that the subject has atherosclerosis. A method is also provided for determining if a pharmaceutical agent is effective for treatment of atherosclerosis in a subject. The method includes assaying the expression of FOS, DUSP1, or both FOS and DUSP1 in a monocytes treated with the pharmaceutical agent, wherein a decrease the expression of FOS, DUSP1, or both FOS and DUSP1 in monocytes in the sample as compared to a control indicates that the pharmaceutical agent is effective for the treatment of atherosclerosis. The monocytes can be contacted with the agent in vivo or in vitro.
REFERENCES:
patent: WO 2004/054428 (2004-07-01), None
Zhao et al, 2007. Arteriocler Thromb Vasc Biol. 27: 886-892 plus supplementary materials; 35 pages as printed.
Rossner et al, 2004. Mutation Research; pp. 55-63.
Davis et al., “Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family,”Immunological Reviews190:123-136, 2002.
Davis et al., “Identification of a family of Fc receptor homologs with preferential B cell expression,”PNAS98(17):9772-9777, Aug. 14, 2001.
Dichtl et al., “The Carboxyl-Terminal Fragment of α1-Antitrypsin is Present in Atherosclerotic Plaques and Regulates Inflammatory Transcription Factors in Primary Human Monocytes,”Molecular Cell Biology Research Communications4:50-61 (2000).
Goetze et al., “TNFα induces expression of transcription factors c-fox, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases ½.”Atherosclerosis159(1):93-101, Nov. 2001.
Hashimoto et al., “Serial Analysis of Gene Expression in Human Monocytes and Macrophages,”Blood94(3):837-844, Aug. 1, 1998.
Küster et al., “Identifying proteins and post-translational modifications by mass spectrometry,”Current Opinion in Structural Biology8:393-400, 1998.
Lavezzi et al., “Expression of c-fos, p53 and PCNA in the unstable atherosclerotic arotid plaque,”Int. J. Cardio.92(1):59-63, Nov. 2003.
Martínez-González et al., “Biología cellular y molecular de las lesions ateroscleróticas,”Rev Esp Cardiol54:218-231, 2001 (English Abstract).
Patino et al., “Circulating transcriptome reveals markers of atheroscleorosis,”PNAS102(9):3423-3428, Mar. 1, 2005.
Patino et al., “Serial Analysis of Gene Expression: Technical Considerations and Applications to Cardiovascular Biology,”Clinical Research91:565-569, 2002.
Rivard et al., “Age-dependent increase in c-fos activity and cylin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis,”Cardiovasc Res45(4):1026-1034, Mar. 2000.
Sartippour et al., “Stimulatory Effect of Glucose on Macrophage Lipoprotein Lipase Expression and Production,”Diabetes47:431-438, Mar. 1998.
Suzuki et al., “Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE,”Blood96(7):2584-2591, Oct. 1, 2000.
Zhukov et al., “From Isolation to Identification,”PharmaGenomicsp. 18-28, Mar./Apr. 2002.
1stAnnual Symposium of the American Heart Association's Council on Basic Cardiovascular Sciences: Stress Signals, Molecular Targets, and the Genome, found at http://www.americanheart.org/presenter.jhtml?identifier=3014865, printed Jul. 23, 2004.
Hwang Paul M.
Kang Ju-Gyeong
Matoba Satoaki
Mian Omar Y.
Patino Willmar D.
Bunner Bridget E
Howard Zachary
Klarquist & Sparkman, LLP
The United States of America as represented by the Secretary of
LandOfFree
Method for assessing atherosclerosis by measuring expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for assessing atherosclerosis by measuring expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for assessing atherosclerosis by measuring expression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2748441